{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:07:55Z","timestamp":1762819675637,"version":"build-2065373602"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00595-025-03093-z","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:55:07Z","timestamp":1751468107000},"page":"1830-1840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of visceral fat with unresectable\/recurrent gastric cancer patients following chemotherapy: a propensity score-matched analysis"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-4251","authenticated-orcid":false,"given":"Ryohei","family":"Nishiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shimakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masano","family":"Sagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Kuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takebumi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"3093_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3093_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet"},{"key":"3093_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340.","journal-title":"Lancet"},{"key":"3093_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00595-023-02721-w","volume":"54","author":"T Matsunaga","year":"2024","unstructured":"Matsunaga T, Satio H, Sakano Y, Makinoya M, Shimizu S, Shishido Y, et al. Prognostic significance of the cachexia index in patients with unresectable advanced gastric cancer receiving palliative chemotherapy: a retrospective single-center study. Surg Today. 2024;54:231\u20139.","journal-title":"Surg Today"},{"key":"3093_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1200\/JCO.2003.04.130","volume":"21","author":"A Ohtsu","year":"2003","unstructured":"Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Japan Clinical Oncology Group S, et al. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2003;21:54\u20139.","journal-title":"J Clin Oncol."},{"key":"3093_CR6","doi-asserted-by":"crossref","unstructured":"Matsui R, Ohashi M, Ri M, Makuuchi R, Irino T, Hayami M, et al. (2024) Oncological impact of the preoperative combined assessment of skeletal muscle mass for patients undergoing curative gastrectomy for gastric cancer. Surg Today. Epub ahead of print.","DOI":"10.1007\/s00595-024-02978-9"},{"key":"3093_CR7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","volume":"26","author":"BJ Caan","year":"2017","unstructured":"Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017;26:1008\u201315.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3093_CR8","first-page":"817","volume":"51","author":"S Li","year":"2017","unstructured":"Li S, Wang Z, Huang J, Fan J, Du H, Liu L, et al. Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the \u2018obesity paradox\u2019 really exist? Eur J Cardiothorac Surg. 2017;51:817\u201328.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3093_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DSM Chan","year":"2014","unstructured":"Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25:1901\u201314.","journal-title":"Ann Oncol"},{"key":"3093_CR10","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-017-6077-y","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yao S, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol. 2017;24:3732\u201340.","journal-title":"Ann Surg Oncol"},{"key":"3093_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ags3.12329","volume":"4","author":"M Iida","year":"2020","unstructured":"Iida M, Takeda S, Nakagami Y, Kanekiyo S, Nakashima C, Nishiyama M, et al. The effect of the visceral fat area on the predictive accuracy of C-reactive protein for infectious complications after laparoscopy-assisted gastrectomy. Ann Gastroenterol Surg. 2020;4:386\u201395.","journal-title":"Ann Gastroenterol Surg"},{"issue":"20","key":"3093_CR12","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.3390\/nu14204236","volume":"14","author":"R Matsui","year":"2022","unstructured":"Matsui R, Inaki N, Tsuji T, Kokura Y, Momosaki R. Preoperative high visceral fat increases severe complications but improves long-term prognosis after gastrectomy for patients with advanced gastric cancer: a propensity score matching analysis. Nutrients. 2022;14(20):4236.","journal-title":"Nutrients"},{"key":"3093_CR13","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.7150\/jca.37270","volume":"11","author":"W Feng","year":"2020","unstructured":"Feng W, Huang M, Zhao X, Chen S, Wang C, Chang J, et al. Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy. J Cancer. 2020;11:3310\u20137.","journal-title":"J Cancer"},{"key":"3093_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer Association","year":"2023","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021. Gastric Cancer. 2023;26:1\u201325.","journal-title":"Gastric Cancer"},{"key":"3093_CR15","unstructured":"Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, Eighth edition. edn, John Wiley & Sons, Inc., Chichester, West Sussex, UK ; Hoboken, NJ; 2017."},{"key":"3093_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1272\/jnms.JNMS.2024_91-405","volume":"91","author":"R Nishiguchi","year":"2024","unstructured":"Nishiguchi R, Furuichi Y, Shimakawa T, Asaka S, Yamaguchi K, Shimojima Y, et al. Visceral fat associated with worsening of recurrent esophageal varices in alcoholic\/nonalcoholic steatohepatitis-related liver cirrhosis. J Nippon Med Sch. 2024;91:362\u201370.","journal-title":"J Nippon Med Sch"},{"key":"3093_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"3093_CR18","unstructured":"US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 40. National Institutes of Health and National Cancer Institute; 2010."},{"key":"3093_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","volume":"18","author":"H Lennon","year":"2016","unstructured":"Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18:56.","journal-title":"Curr Oncol Rep"},{"key":"3093_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10120-018-0818-x","volume":"21","author":"JH Lee","year":"2018","unstructured":"Lee JH, Park B, Joo J, Kook MC, Kim YI, Lee JY, et al. Body mass index and mortality in patients with gastric cancer: a large cohort study. Gastric Cancer. 2018;21:913\u201324.","journal-title":"Gastric Cancer"},{"key":"3093_CR21","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1245\/s10434-015-4432-4","volume":"22","author":"K Harada","year":"2015","unstructured":"Harada K, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, et al. Low visceral fat content is associated with poor prognosis in a database of 507 upper gastrointestinal cancers. Ann Surg Oncol. 2015;22:3946\u201353.","journal-title":"Ann Surg Oncol"},{"key":"3093_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111619","volume":"97","author":"R Matsui","year":"2022","unstructured":"Matsui R, Inaki N, Tsuji T. Impact of visceral adipose tissue on long-term outcomes after gastrectomy for advanced gastric cancer. Nutrition. 2022;97: 111619.","journal-title":"Nutrition"},{"key":"3093_CR23","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","volume":"25","author":"HS Park","year":"2018","unstructured":"Park HS, Kim HS, Beom SH, Rha SY, Chung HC, Kim JH, et al. Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial. Ann Surg Oncol. 2018;25:3222\u201330.","journal-title":"Ann Surg Oncol"},{"key":"3093_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.589022","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang C, Peng Z, Qi C, Gong J, Zhang X, et al. Association of lymphocyte-to-monocyte ratio with survival in advanced gastric cancer patients treated with immune checkpoint inhibitor. Front Oncol. 2021;11: 589022.","journal-title":"Front Oncol"},{"key":"3093_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039917","volume":"103","author":"H Deng","year":"2024","unstructured":"Deng H, He Y, Huang G, Huang Y, Wu J, Qin X. Predictive value of prognostic nutritional index in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2024;103: e39917.","journal-title":"Medicine (Baltimore)"},{"key":"3093_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013896","volume":"97","author":"YC Pan","year":"2018","unstructured":"Pan YC, Jia ZF, Cao DH, Wu YH, Jiang J, Wen SM, et al. Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients. Medicine (Baltimore). 2018;97: e13896.","journal-title":"Medicine (Baltimore)"},{"key":"3093_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00595-024-02813-1","volume":"54","author":"N Fukushima","year":"2024","unstructured":"Fukushima N, Masuda T, Tsuboi K, Takahashi K, Yuda M, Fujisaki M, et al. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer. Surg Today. 2024;54:943\u201352.","journal-title":"Surg Today"},{"key":"3093_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00595-024-02921-y","volume":"55","author":"J Li","year":"2024","unstructured":"Li J, Zhang S, Hu X, Huang T, Chen M. Correlation between the C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index and the prognosis of gastric cancer patients after gastrectomy: a systematic review and meta-analysis. Surg Today. 2024;55:483\u201391.","journal-title":"Surg Today"},{"key":"3093_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","volume":"20","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer. 2017;20:111\u201321.","journal-title":"Gastric Cancer"},{"key":"3093_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jjco\/hyh120","volume":"34","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Ohtsu A, Boku N, Miyata Y, Shirao K, Shimada Y, et al. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol. 2004;34:654\u20139.","journal-title":"Jpn J Clin Oncol"},{"key":"3093_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.plefa.2005.04.010","volume":"73","author":"S Cinti","year":"2005","unstructured":"Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005;73:9\u201315.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"3093_CR32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763\u201370.","journal-title":"Nature"},{"key":"3093_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ajh.10363","volume":"73","author":"CW Choi","year":"2003","unstructured":"Choi CW, Sung HJ, Park KH, Yoon SY, Kim SJ, Oh SC, et al. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Am J Hematol. 2003;73:263\u20136.","journal-title":"Am J Hematol"},{"key":"3093_CR34","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1182\/blood.V82.12.3515.3515","volume":"82","author":"D Metcalf","year":"1993","unstructured":"Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 1993;82:3515\u201323.","journal-title":"Blood"},{"key":"3093_CR35","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00595-024-02850-w","volume":"54","author":"T Matsunaga","year":"2024","unstructured":"Matsunaga T, Saito H, Osaki T, Fukuda K, Fukumoto Y, Takahashi S, et al. Using the geriatric nutritional risk index to predict outcomes in older patients with remnant gastric cancer after gastrectomy: a retrospective multicenter study in Japan. Surg Today. 2024;54:1360\u20138.","journal-title":"Surg Today"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-025-03093-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:03:10Z","timestamp":1762819390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-025-03093-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3093"],"URL":"https:\/\/doi.org\/10.1007\/s00595-025-03093-z","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"type":"print","value":"0941-1291"},{"type":"electronic","value":"1436-2813"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest associated with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in accordance with the ethical principles of the Declaration of Helsinki (Fortaleza, October 2013). The study protocol was approved by the institutional review board of Tokyo Women\u2019s Medical University (Approval No. 2021-0186).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Tokyo Women\u2019s Medical University Ethics Committee waived the requirement for informed consent. Instead, opt-out consent was approved by the committee and made available on our websites, where permission was requested to use the personal information of the participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}